Comparative safety of different recommended doses of sodium–glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials

OBJECTIVE: The safety results of different recommended doses of sodium-glucose cotransporter 2 inhibitors (SGLT-2i) for patients with type 2 diabetes mellitus (T2DM) remain uncertain. This study aims to comprehensively estimate and rank the relative safety outcomes with different doses of SGLT-2i fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lu, Xue, Qingxia, Yan, Chunyan, Tang, Bingying, Wang, Lu, Zhang, Bei, Zhao, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667926/
https://www.ncbi.nlm.nih.gov/pubmed/38027214
http://dx.doi.org/10.3389/fendo.2023.1256548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667926/
https://www.ncbi.nlm.nih.gov/pubmed/38027214
http://dx.doi.org/10.3389/fendo.2023.1256548

Ejemplares similares